Related Experiment Video

Updated: Jun 4, 2025

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
03:19

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

362

The Prevention of Maternal Phenylketonuria (PKU) Syndrome: The Development and Evaluation of a Specific Training

Carmen Rohde1, Alena Gerlinde Thiele1, Anne Tomm1

  • 1Department of Women and Child Health, Hospital for Children and Adolescents, University Hospitals, University of Leipzig, Liebigstraße 20 a, 04103 Leipzig, Germany.

Nutrients
|December 17, 2024
PubMed

Insights

Maternal phenylketonuria (PKU) can harm unborn children. A group training program significantly improved knowledge of PKU therapy and pregnancy for young women with PKU and their partners, leading to healthier outcomes.

Area of Science:

  • Metabolic disorders
  • Genetics
  • Maternal-fetal medicine

Background:

  • Maternal phenylketonuria (PKU) syndrome poses significant risks to unborn children, including psychomotor retardation, microcephaly, and cardiac defects, due to insufficient metabolic control during pregnancy.
  • A specific prevention program was developed to mitigate these risks and improve long-term outcomes for affected offspring.

Purpose of the Study:

  • To evaluate the effectiveness of a group training program designed for young women with PKU and their partners.
  • To assess improvements in knowledge regarding PKU therapy and pregnancy, as well as changes in anxiety and depression scores.

Main Methods:

  • A group training program was implemented for young women with PKU (age >14 years) and their partners.
  • Knowledge was assessed using a multiple-choice questionnaire, and anxiety and depression scores were evaluated before and after the program.

Main Results:

  • Significant improvements in knowledge were observed in both patients (86% to 90%) and partners (78% to 89%).
  • Female patients showed significant gains in understanding diet and metabolism but not gynecological aspects.
  • Anxiety and depression scores remained stable and within normative ranges, with four pregnancies resulting in healthy offspring among trained mothers.

Conclusions:

  • The study suggests incorporating specific training programs into the standard care for young adult women with PKU and their partners.
  • These programs can enhance knowledge and potentially improve pregnancy outcomes in maternal PKU cases.
Abstract

Keywords:
maternal PKU syndromepreconceptional trainingpregnancy in phenylketonuria (PKU)preventiontraining program

More Related Videos

A Treatment Package without Escape Extinction to Address Food Selectivity04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

11.5K
Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development05:44

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

515

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
127
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
723
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
862
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
141